Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824610 | Clinical Therapeutics | 2015 | 25 Pages |
Abstract
In conclusion, the model predicted that MMRV vaccination can significantly reduce varicella incidence. With suboptimal coverage, a limited age shift of varicella cases is predicted to occur post-vaccination with MMRV. However, it does not result in an increase in the number of complications. GSK study identifier: HO-12-6924.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mario J.N.M. PhD, Kavi J. MSc, Christophe MSc, Bertrand MSc, PhD, François MD, PhD, Pierre-Yves PhD, Sophie MD, PhD,